The Triple Aim
How Doctors Choose Between Antibiotics, Antivirals, and “Watchful Waiting”
When a patient comes in with a sore throat, cough, and fever, one of the most common expectations is a prescription for antibiotics. Yet, more often than not, a good doctor will leave the prescription pad untouched. The decision of whether to treat with an antibiotic, an antiviral, or simply recommend supportive care is a complex balancing act that considers the patient’s immediate symptoms, the underlying cause, the risk of harm, and the broader public health implications.
The first and most critical step is determining the etiology—what is causing the illness? Antibiotics target bacteria. Antivirals target viruses. Neither works against the other. The vast majority of upper respiratory infections—colds, flu, most sore throats, most sinus infections, and most bronchitis—are viral. Prescribing an antibiotic for a viral illness is not just ineffective; it’s actively harmful.
So how does a clinician decide? The process begins with pattern recognition.
For a sore throat: A doctor uses the Centor criteria. If a patient has a fever, absence of cough, swollen tender lymph nodes, and tonsillar exudate (white patches), they score points. A high score suggests Group A Streptococcus (bacterial), and a rapid strep test or culture will confirm. Without these features, the sore throat is almost certainly viral. No antibiotic is prescribed.
For sinusitis: The key distinction is duration and pattern. Viral sinusitis is the norm for the first 10 days. A doctor will only consider antibiotics if symptoms persist beyond 10 days without improvement, or if there is a “double worsening”—the patient starts to improve, then suddenly spikes a fever with worsening facial pain. This pattern suggests a bacterial superinfection.
For bronchitis: Acute bronchitis is almost always viral. The hallmark is a cough that lingers for weeks. Even if the phlegm turns green or yellow, this is a sign of the immune system at work, not necessarily a bacterial infection. Antibiotics do not shorten the course of viral bronchitis, but they do cause side effects and contribute to resistance.
When a bacterial infection is confirmed or highly suspected, the choice of which antibiotic becomes a further exercise in precision. A doctor will consider:
Local resistance patterns: In some communities, amoxicillin is no longer effective against common strains of strep or pneumococcus, so a doctor may choose amoxicillin-clavulanate (Augmentin) or a cephalosporin instead.
Patient allergies: Penicillin allergies are common and often dictate a switch to macrolides (like azithromycin) or respiratory fluoroquinolones (like levofloxacin).
Site of infection: A simple urinary tract infection may be treated with nitrofurantoin, which concentrates in the urine. A kidney infection (pyelonephritis) requires a drug that penetrates deep into renal tissue, like ciprofloxacin.
Pregnancy: Tetracyclines are avoided due to effects on fetal bone and teeth development; penicillins and cephalosporins are generally preferred.
The final layer is the practice of watchful waiting, often called a “safety net prescription.” A doctor may provide a prescription but instruct the patient not to fill it unless symptoms worsen or fail to improve in a specific timeframe (e.g., 48–72 hours). This approach satisfies the patient’s desire for a plan, reduces unnecessary antibiotic use, and empowers the patient to participate in their own care. The goal is not to withhold treatment, but to ensure that when an antibiotic is finally used, it is truly necessary—protecting both the individual patient and the community from the growing threat of antimicrobial resistance.